CME Challenges Nasdaq’s Bitcoin Options: SEC Intervenes and Suspends Approval

CME Group has challenged the approval granted to Nasdaq for Bitcoin index options, arguing that Bitcoin is a commodity, leading the SEC to halt the process for further review.

As jurisdictional disputes in the cryptocurrency markets reach new heights, the U.S. Securities and Exchange Commission (SEC) has suspended Nasdaq‘s plan to list cash-settled Bitcoin index options following an objection from major exchange operator CME Group. CME asserts that these investment instruments are not securities but rather commodity option contracts that fall entirely under the jurisdiction of the Commodity Futures Trading Commission (CFTC). This move has once again escalated tensions over which agency will oversee the Bitcoin derivatives market.

Jurisdictional War in the Bitcoin Derivatives Market

CME Group maintains that Bitcoin holds commodity status and that options directly based on the asset’s value must remain under the CFTC‘s exclusive jurisdiction. The company warns that the SEC is pushing its regulatory boundaries by overstepping relevant provisions of the Dodd-Frank Act, and that this decision could set a dangerous precedent for other commodities. Nasdaq supports its project, arguing that these products—slated to trade under the symbol QBTC—will provide spot Bitcoin ETF investors with hedging opportunities under the same exchange umbrella.

The SEC accepted CME’s petition and froze the previously granted conditional approval until the review process is completed. Representing the agency’s regulatory authority, this review decision will remain uncertain until August 24, the deadline for parties to submit their views. The resulting decision will directly affect not only the future of Bitcoin options but also the legal classification of crypto assets in the U.S. and the balance of power between regulatory bodies.